Silence Therapeutics plc (NASDAQ:SLN) Receives $33.83 Consensus Target Price from Brokerages
Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average twelve-month […]
Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average twelve-month […]
